AKT1 and non-small cell lung carcinoma: Furthermore, by focusing on the Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT-1), MiR-101-3p blocked the PI3K/AKT signal pathway, hence reducing NSCLC development and metastasis [120].